pharmaceutical investing Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
pharmaceutical investing Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU
pharmaceutical investing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
pharmaceutical investing AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases at 2026 Digestive Disease Week®
pharmaceutical investing Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
pharmaceutical investing SKYRIZI® Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis
pharmaceutical investing AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
LaFleur Expands Swanson Gold Deposit System, Confirming Strong Continuity with 2.95 g/t Au over 80.00 metres and 2.37 g/t Au over 88.05 metres
Yukon Metals Just Optioned a Sumitomo-Drilled Copper-Gold Project Next to Its Birch Discovery - Here's What's Now in Play in the Yukon
